CAJ | 학술논문

2012年1月美国发生巴西橙汁多菌灵超标事件后，为便于指导我国农产品出口企业规避出口风险，本文重点分析了国际食品法典委员会(CAC)、美国、欧盟、日本、巴西、韩国、加拿大及我国对多菌灵残留限量标准的要求，并进行对比分析，指出美国食品药品管理局(FDA)新举措可能对我国果蔬(果汁)行业产生的影响。建议重点开展苹果汁中多菌灵含量的风险评估工作，以应对美国市场的潜在风险；强化对进口橙汁的多菌灵含量的监测，避免高残留农药产品冲击国内市场。
2012년1월미국발생파서등즙다균령초표사건후，위편우지도아국농산품출구기업규피출구풍험，본문중점분석료국제식품법전위원회(CAC)、미국、구맹、일본、파서、한국、가나대급아국대다균령잔류한량표준적요구，병진행대비분석，지출미국식품약품관리국(FDA)신거조가능대아국과소(과즙)행업산생적영향。건의중점개전평과즙중다균령함량적풍험평고공작，이응대미국시장적잠재풍험；강화대진구등즙적다균령함량적감측，피면고잔류농약산품충격국내시장。
This paper mainly analyzes the requirements of carbendazim residue limit standards of the Codex Alimentarius Commission (CAC), the United States, European Union, Japan, Brazil, South Korea, Canada and China for guiding enterprises to advoid export risks after the incident about Brazilian orange juice carbendazim excess in January 2012, America and points out FDA new measures, influences on our fruits (juice) industries. Standards on carbendazim residue limit amount at home and abroad were comparatively analyzed in this article, and the probable impact of FDA new measures on domestic fruit juice industry was pointed out. It is suggested that risk assessments of carbendazim content in apple juice should be carried out to deal with the potential risks of American market and the monitoring of carbendazim content in imported orange juice should be strengthened to avoid the impact of high residual products on the domestic market.